title: Mycophenolate mofetil decreases atherosclerotic lesion size by depression of aortic T-lymphocyte and interleukin-17-mediated macrophage accumulation.
abstract: OBJECTIVE
  This study tested whether immunosuppression with mycophenolate mofetil (MMF) inhibits atherosclerosis development in apolipoprotein-E-deficient (Apoe(-/-)) mice and investigated the mechanism.
  
  
  BACKGROUND
  Chronic vascular inflammation involving both innate and adaptive immunity is central in the development of atherosclerosis, but immunosuppressive treatment is not uniformly beneficial. The immunosuppressive MMF targets lymphocyte proliferation by inhibiting inosine-monophosphate dehydrogenase.
  
  
  METHODS
  Young and aged Apoe(-/-) mice were treated with 30 mg/kg daily MMF during 12 and 3 weeks of a high-fat diet, respectively. Aortic lesion size and composition was investigated by histology and flow cytometry; soluble inflammatory mediators were investigated by enzyme-linked immunosorbent assay.
  
  
  RESULTS
  Macroscopic and histologic aortic atherosclerotic lesions were significantly decreased in both MMF-treated groups. While systemic immunoglobulin G directed against low-density lipoproteins was not significantly altered, the T-cell cytokine interleukin (IL)-17 was significantly reduced in plasma of MMF-treated mice and supernatants from their aortas after T-cell stimulation. The MMF treatment decreased aortic αβ T-cell receptor(+) lymphocyte proliferation and cell numbers. Also, aortic contents of CD11b(+)CD11c(+) cells and their proliferation were reduced in MMF-treated Apoe(-/-) mice. The IL-17 supplementation restored the number of proliferating aortic CD11b(+)CD11c(+) cells in MMF-treated mice. The IL-17 receptor A was highly expressed on circulating monocytes that are macrophage progenitors. Genetic deletion of IL-17 receptor A or IL-17A reduced inflammatory peritoneal CD11b(+)CD11c(+) macrophage accumulation.
  
  
  CONCLUSIONS
  The lymphocyte-directed immunosuppressant MMF that curbs IL-17 production was a successful antiatherosclerotic treatment. Our data delineate a role for IL-17 in CD11b(+)CD11c(+) cell accumulation.
authors: Sibylle
authors: S
authors: von Vietinghoff
authors: Ekaterina K
authors: EK
authors: Koltsova
authors: Javier
authors: J
authors: Mestas
authors: Cody J
authors: CJ
authors: Diehl
authors: Joseph L
authors: JL
authors: Witztum
authors: Klaus
authors: K
authors: Ley
references: Kidney Int. 2010 Jul;78(1):79-88
references: 20375992
references: Circulation. 2007 Jan 30;115(4):501-8
references: 17242282
references: Nat Rev Immunol. 2008 Oct;8(10):802-15
references: 18825131
references: J Heart Lung Transplant. 2006 May;25(5):550-6
references: 16678034
references: J Clin Invest. 2002 Mar;109(6):745-53
references: 11901183
references: J Clin Invest. 2004 Aug;114(3):427-37
references: 15286809
references: J Exp Med. 2009 Sep 28;206(10):2067-77
references: 19737863
references: J Clin Invest. 1995 Sep;96(3):1389-94
references: 7657813
references: Am J Pathol. 1995 Sep;147(3):668-77
references: 7677178
references: J Clin Invest. 2007 Jan;117(1):185-94
references: 17200718
references: Arterioscler Thromb Vasc Biol. 2007 Nov;27(11):2392-9
references: 17761943
references: Atherosclerosis. 2000 Sep;152(1):127-33
references: 10996347
references: Transplantation. 1998 Aug 27;66(4):507-15
references: 9734496
references: Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2493-5
references: 17901372
references: Arterioscler Thromb Vasc Biol. 2007 Mar;27(3):607-13
references: 17158351
references: J Lipid Res. 2009 Apr;50 Suppl:S364-9
references: 19050311
references: J Exp Med. 2009 Sep 28;206(10):2141-9
references: 19752185
references: Cardiovasc Res. 2006 Feb 1;69(2):341-7
references: 16289002
references: Atherosclerosis. 2010 Jul;211(1):231-6
references: 20202636
references: Ann N Y Acad Sci. 2007 Sep;1110:209-21
references: 17911436
references: J Immunol. 2009 Dec 15;183(12):8167-75
references: 20007582
references: Exp Mol Pathol. 1989 Aug;51(1):1-8
references: 2767215
references: Nat Rev Immunol. 2006 Jul;6(7):508-19
references: 16778830
references: Arterioscler Thromb Vasc Biol. 2002 Nov 1;22(11):1892-8
references: 12426221
references: Nat Med. 2006 Feb;12(2):178-80
references: 16462800
references: Circulation. 2010 Apr 20;121(15):1746-55
references: 20368519
references: Am J Pathol. 1993 Jun;142(6):1927-37
references: 8099471
references: Curr Opin Chem Biol. 2006 Oct;10(5):520-5
references: 16919497
references: Arterioscler Thromb. 1991 May-Jun;11(3):745-50
references: 2029509
references: Am J Transplant. 2002 Oct;2(9):807-18
references: 12392286
references: Circulation. 2009 May 26;119(20):2708-17
references: 19433759
references: Immunopharmacology. 2000 May;47(2-3):85-118
references: 10878285
references: J Exp Med. 2008 Sep 29;205(10):2281-94
references: 18779348
references: J Exp Med. 2006 May 15;203(5):1273-82
references: 16682495
references: J Surg Res. 2000 Jun 15;91(2):123-9
references: 10839960
references: Circulation. 2009 May 5;119(17):2367-75
references: 19380622
references: Circ Res. 2008 Oct 24;103(9):965-73
references: 18832748
references: Nat Med. 2003 Jun;9(6):736-43
references: 12740573
references: Biochem Biophys Res Commun. 2009 Oct 16;388(2):261-5
references: 19660432
references: N Engl J Med. 2004 Dec 23;351(26):2715-29
references: 15616206
references: Lancet. 2006 May 27;367(9524):1747-57
references: 16731270
references: Nature. 2008 Jun 19;453(7198):1051-7
references: 18563156